What are the most likely heart anomalies in individuals with trisomy 21 (Down syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Heart Anomalies in Trisomy 21 (Down Syndrome)

Atrioventricular septal defect (AVSD) is the most characteristic cardiac anomaly in individuals with Down syndrome, though ventricular septal defect (VSD) may be the most frequently occurring defect depending on the population studied. 1

Primary Cardiac Defects

The distribution of congenital heart defects in trisomy 21 shows important patterns:

Most Common Defects

  • Atrioventricular septal defect (AVSD) is widely recognized as the hallmark cardiac anomaly in Down syndrome, occurring in approximately 15-30% of affected individuals 1, 2

    • AVSD is so strongly associated with trisomy 21 that approximately 65% of all AVSD cases occur in individuals with Down syndrome 3
    • Type 3 (Inlet) VSDs are particularly associated with Down syndrome 4
  • Ventricular septal defect (VSD) represents the most common defect in some populations, particularly Asian cohorts, occurring in 22-39% of cases 5, 2

    • One large Asian study found VSD in 39.2% of trisomy 21 patients, making it the most frequent cardiac lesion in that population 5
  • Atrial septal defect (ASD), particularly secundum type, occurs in 23-28% of cases 5, 6, 2

  • Patent ductus arteriosus (PDA) is found in 5-34% of individuals with Down syndrome 5, 6, 2

Less Common but Important Defects

  • Tetralogy of Fallot occurs in approximately 3% of cases, with a notably high proportion (25%) of these patients also having AVSD 5, 2

  • Coarctation of the aorta occurs in approximately 5% of cases 2

Clinical Implications and Pitfalls

Key Management Considerations

  • Approximately 40-73% of individuals with Down syndrome have congenital heart defects, making cardiac screening essential in all cases 1, 6, 7

  • Early echocardiographic evaluation is mandatory for all infants diagnosed with trisomy 21, regardless of clinical symptoms 1

  • Genetic evaluation is recommended for all patients with CHD accompanied by extracardiac malformations or neurodevelopmental abnormalities 1

Important Caveats

  • Population-based variation exists: Western/Caucasian populations show higher rates of AVSD as the predominant defect, while Asian populations demonstrate VSD as most common 5

  • Multiple defects frequently coexist: A significant proportion of patients have more than one cardiac anomaly, requiring comprehensive echocardiographic assessment 5, 2

  • Pulmonary hypertension risk: Patients with Down syndrome and AVSD are at particular risk for developing pulmonary arterial hypertension and require careful monitoring 1

Follow-Up Requirements

  • All patients require periodic follow-up with a cardiologist experienced in adult congenital heart disease, typically annually, though frequency depends on residual abnormalities 1

  • Serial imaging with 2-dimensional and Doppler echocardiography should be performed by staff trained in complex congenital heart defects 1

  • Late complications include AV valve regurgitation or stenosis (5-10% requiring reoperation), left ventricular outflow tract obstruction (5%), and development of heart block 1

Reproductive Counseling

  • Individuals with Down syndrome and AVSD have a 50% risk of transmitting trisomy 21 and other genetic defects to offspring, warranting reproductive counseling 1

  • Pregnancy evaluation is essential before conception to ensure no significant residual hemodynamic lesions exist that might complicate pregnancy management 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Associated congenital anomalies among cases with Down syndrome.

European journal of medical genetics, 2015

Guideline

Ventricular Septal Defect Epidemiology and Classification

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ALK2 mutation in a patient with Down's syndrome and a congenital heart defect.

European journal of human genetics : EJHG, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.